Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine

被引：0

作者：

Chen, Chun-Bing ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
,11
,12
,13
,14
,15
]}

机构：

[1] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Linkou, Taiwan

[2] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Taipei, Taiwan

[3] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Tucheng, Taiwan

[4] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Keelung, Taiwan

[5] Chang Gung Mem Hosp, Dept Med Res, Canc Vaccine & Immune Cell Therapy Core Lab, Linkou, Taiwan

[6] Chang Gung Mem Hosp, Dept Med Res, Canc Vaccine & Immune Cell Therapy Core Lab, Taoyuan, Taiwan

[7] Chang Gung Univ, Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan

[8] Xiamen Chang Gung Hosp, Dept Dermatol, Xiamen, Peoples R China

[9] Xiamen Chang Gung Hosp, Xiamen Chang Gung Allergol Consortium, Xiamen, Peoples R China

[10] Natl Tsing Hua Univ, Sch Med, Hsinchu, Taiwan

[11] Chang Gung Univ, Coll Med, Taoyuan, Taiwan

[12] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan

[13] Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Linkou, Taiwan

[14] Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Taoyuan, Taiwan

[15] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Linkou Main Branch, 5 Fusing St, Taoyuan 333, Taiwan

来源：

DERMATOLOGICA SINICA | 2023年 / 41卷 / 04期

关键词：

D O I：

10.4103/DS.V41-4-Editorial

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：181 / 182

页数：2

共 50 条

[1] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
Kloypan, Chiraphat
Koomdee, Napatrupron
Satapornpong, Patompong
Tempark, Therdpong
Biswas, Mohitosh
Sukasem, Chonlaphat
[J]. PHARMACEUTICALS, 2021, 14 (11)
[2] Pharmacogenomics of adverse drug reactions: implementing personalized medicine
Wei, Chun-Yu
Lee, Ming-Ta Michael
Chen, Yuan-Tsong
[J]. HUMAN MOLECULAR GENETICS, 2012, 21 : R58 - R65
[3] Pharmacogenomics of severe cutaneous adverse reactions
Kaniwa, Nahoko
Saito, Yoshiro
[J]. PHARMACOGENOMICS, 2013, 14 (06) : 595 - 598
[4] Pharmacogenomics of adverse drug reactions
Daly, Ann K.
[J]. GENOME MEDICINE, 2013, 5
[5] Pharmacogenomics and adverse drug reactions
Chiba, K
[J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 46P - 46P
[6] Pharmacogenomics of adverse drug reactions
Ann K Daly
[J]. Genome Medicine, 5
[7] Pharmacogenomics and adverse drug reactions
Amur, Shashi
Zineh, Issam
Abernethy, Darrell R.
Huang, Shiew-Mei
Lesko, Lawrence J.
[J]. PERSONALIZED MEDICINE, 2010, 7 (06) : 633 - 642
[8] Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
Alessandrini, Marco
Chaudhry, Mamoonah
Dodgen, Tyren M.
Pepper, Michael S.
[J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2016, 20 (10) : 593 - 603
[9] Pharmacogenomics: Precision Medicine and Drug Response
Weinshilboum, Richard M.
Wang, Liewei
[J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (11) : 1711 - 1722
[10] Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach
Tan-Koi, Wei Chuen
Sung, Cynthia
Chong, Yong Yeow
Lateef, Aisha
Pang, Shiu Ming
Vasudevan, Archana
Derrick, A. W.
Lui, Nai Lee
Lee, Shan Xian
Ren, Ee Chee
Koay, Evelyn S. C.
Tay, Yong Kwang
Lim, Yen Loo
Lee, Haur Yueh
Dong, Di
Loke, Celine
Tan, Liesbet
Limenta, Michael
Lee, Edmund J. D.
Toh, Dorothy
Chan, Cheng Leng
[J]. PHARMACOGENOMICS, 2017, 18 (09) : 865 - 874

← 1 2 3 4 5 →